Enhanced immunoreceptor tyrosine-based activation motif signaling is related to pathological bone resorption during critical illness

Hormone and Metabolic Research

Volumn 45, Issue 12, 2013, Pages 862-869

  Vanhees, I ^a   Gunst, J ^a   Janssens, T ^a   Wauters, A ^a   Van Herck, E ^b   Van Cromphaut, S ^a   Van Den Berghe, G ^a   Owen, H C ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

bone hyperresorption; intensive care unit; ITAM; osteoblast; osteoclast

Indexed keywords

CALCIUM ION; CD16 ANTIGEN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BURN; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IN VIVO STUDY; MALE; MEDIATOR; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RABBIT; SERUM; SIGNAL TRANSDUCTION; TISSUE LEVEL; TRABECULAR BONE; VASCULARIZATION;

ORYCTOLAGUS CUNICULUS;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; CALCIUM; CRITICAL ILLNESS; GENE EXPRESSION REGULATION; HUMANS; IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF; IONS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; RABBITS; SIGNAL TRANSDUCTION;

EID: 84887842667     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1351290     Document Type: Article

References (32)

1. Van den Berghe G., de Zegher F., Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab: 1998; 83 1827 1834 (Pubitemid 28496301)
2. Nelson J. E., Cox C. E., Hope A. A., Carson S. S. Chronic critical illness. Am J Respir Crit Care Med: 2010; 182 446 454
3. Hermans G., Vanhorebeek I., Derde S., Van den Berghe G. Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med: 2009; 37 S391 S397
4. Van den Berghe G. Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin North Am: 2003; 32 385 410
5. Parfitt A. M. The bone remodeling compartment: a circulatory function for bone lining cells. J Bone Miner Res: 2001; 16 1583 1585 (Pubitemid 32786426)
6. Nierman D. M., Mechanick J. I. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest: 2000; 118 761 766
7. Smith L. M., Cuthbertson B., Harvie J., Webster N., Robins S., Ralston S. H. Increased bone resorption in the critically ill: association with sepsis and increased nitric oxide production. Crit Care Med: 2002; 30 837 840 (Pubitemid 34297804)
8. Van den Berghe G., Van Roosbroeck D., Vanhove P., Wouters P. J., De Pourcq L., Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab: 2003; 88 4623 4632 (Pubitemid 37357503)
9. Fink E., Cormier C., Steinmetz P., Kindermans C., Le Bouc Y., Souberbielle J. C. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Osteoporos Int: 2000; 11 295 303 (Pubitemid 30417181)
10. Orford N. R., Saunders K., Merriman E., Henry M., Pasco J., Stow P., Kotowicz M. Skeletal morbidity among survivors of critical illness. Crit Care Med: 2011; 39 1295 1300
11. Owen H. C., Vanhees I., Solie L., Roberts S. J., Wauters A., Luyten F. P., Van Cromphaut S., Van den Berghe G. Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalities. J Bone Miner Res: 2012; 27 1541 1552
12. Chiu Y. G., Shao T., Feng C., Mensah K. A., Thullen M., Schwarz E. M., Ritchlin C. T. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther: 2010; 12 R14
13. Crotti T. N., Dharmapatni A. A., Alias E., Zannettino A. C., Smith M. D., Haynes D. R. The immunoreceptor tyrosine-based activation motif (ITAM)-related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. Arthritis Res Ther: 2012; 14 R245
14. Weekers F., Giulietti A. P., Michalaki M., Coopmans W., Van Herck E., Mathieu C., Van den Berghe G. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology: 2003; 144 5329 5338 (Pubitemid 37476061)
15. Bouillon R., Vanderschueren D., Van Herck E., Nielsen H. K., Bex M., Heyns W., Van Baelen H. Homologous radioimmunoassay of human osteocalcin. Clin Chem: 1992; 38 2055 2060
16. Sanjai K., Kumarswamy J., Patil A., Papaiah L., Jayaram S., Krishnan L. Evaluation and comparison of decalcification agents on the human teeth. J Oral Maxillofac Pathol: 2012; 16 222 227
17. Roberts S. J., Geris L., Kerckhofs G., Desmet E., Schrooten J., Luyten F. P. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials: 2011; 32 4393 4405
18. Jaquiery C., Schaeren S., Farhadi J., Mainil-Varlet P., Kunz C., Zeilhofer H. F., Heberer M., Martin I. In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Ann Surg: 2005; 242 859 867 discussion 867-868
19. Livak K. J., Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods: 2001; 25 402 408 (Pubitemid 34164012)
20. Mocsai A., Humphrey M. B., Van Ziffle J. A., Hu Y., Burghardt A., Spusta S. C., Majumdar S., Lanier L. L., Lowell C. A., Nakamura M. C. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA: 2004; 101 6158 6163 (Pubitemid 38520544)
21. Dominioni L., Trocki O., Fang C. H., Mochizuki H., Ray M. B., Ogle C. K., Alexander J. W. Enteral feeding in burn hypermetabolism: nutritional and metabolic effects of different levels of calorie and protein intake. JPEN J Parenter Enteral Nutr: 1985; 9 269 279 (Pubitemid 15032924)
22. Miller S. C., Bowman B. M., Siska C. C., Shelby J. Effects of thermal injury on skeletal metabolism in two strains of mice. Calcif Tissue Int: 2002; 71 429 436 (Pubitemid 36929606)
23. Klein G. L., Herndon D. N., Langman C. B., Rutan T. C., Young W. E., Pembleton G., Nusynowitz M., Barnett J. L., Broemeling L. D., Sailer D. E., McCauley R. L. Long-term reduction in bone mass after severe burn injury in children. J Pediatr: 1995; 126 252 256
24. Klein G. L., Herndon D. N., Goodman W. G., Langman C. B., Phillips W. A., Dickson I. R., Eastell R., Naylor K. E., Maloney N. A., Desai M., Benjamin D., Alfrey A. C. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone: 1995; 17 455 460
25. Egi M., Kim I., Nichol A., Stachowski E., French C. J., Hart G. K., Hegarty C., Bailey M., Bellomo R. Ionized calcium concentration and outcome in critical illness. Crit Care Med: 2011; 39 314 321
26. Ruegsegger P., Medici T. C., Anliker M. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol: 1983; 25 615 620 (Pubitemid 14211628)
27. Baofeng L., Zhi Y., Bei C., Guolin M., Qingshui Y., Jian L. Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid. Acta Orthop: 2011; 81 396 401
28. Hott M., Deloffre P., Tsouderos Y., Marie P. J. S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone: 2003; 33 115 123 (Pubitemid 36952693)
29. Gaudio A., Pennisi P., Bratengeier C., Torrisi V., Lindner B., Mangiafico R. A., Pulvirenti I., Hawa G., Tringali G., Fiore C. E. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab: 2010; 95 2248 2253
30. Zhao R. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective. Int J Med Sci: 2012; 9 825 832
31. Chiu Y. H., Mensah K. A., Schwarz E. M., Ju Y., Takahata M., Feng C., McMahon L. A., Hicks D. G., Panepento B., Keng P. C., Ritchlin C. T. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res: 2012; 27 79 92
32. Nose M., Yamazaki H., Hagino H., Morio Y., Hayashi S., Teshima R. Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients. J Bone Miner Metab: 2009; 27 57 65